Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt vs. Deferred Laser Treatment: 5-year Randomized Trial Results

OBJECTIVE: To report 5-year results from a previously reported trial evaluating intravitreal 0.5-mg ranibizumab with prompt versus deferred (for ≥24 weeks) focal/grid laser treatment for diabetic macular edema (DME). DESIGN: Multicenter randomized clinical trial. PARTICIPANTS: Among participants fro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ophthalmology
Asıl Yazarlar: Elman, Michael J., Ayala, Allison, Bressler, Neil M., Browning, David, Flaxel, Christina J., Glassman, Adam R., Jampol, Lee M., Stone, Thomas W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4520307/
https://ncbi.nlm.nih.gov/pubmed/25439614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2014.08.047
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller